Shanghai Haohai Biological Technology Co., Ltd. (688366.SH) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	2.3B	2.5B	2.7B	2.7B	2.1B
Cost of Revenue	795.4M	738.8M	812.6M	782.8M	660.8M
Gross Profit	1.5B	1.7B	1.9B	1.9B	1.5B
Operating Expenses
R&D Expense	186.2M	197.8M	238.9M	220.1M	182.2M
SG&A Expense	551.7M	—	—	—	—
General & Admin Expense	190.5M	428.7M	442.7M	417.8M	402.3M
Selling & Marketing Expense	376.2M	814.8M	780.8M	814.5M	679.5M
Other Expenses	30.3M	—	—	—	—
Total Operating Expenses	1.3B	1.4B	1.4B	1.4B	1.2B
Cost and Expenses	2.1B	2.1B	2.2B	2.2B	1.9B
Operating Income (EBIT)	33.0M	220.2M	494.8M	507.4M	234.6M
Non-Operating
Interest Income	23.3M	—	—	—	—
Interest Expense	5.1M	—	—	—	—
Net Interest Income	18.2M	—	—	—	—
Other Non-Op Income/Expense	48.9M	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	81.2M	239.2M	466.1M	508.3M	235.7M
Income Tax Expense	7.1M	30.9M	89.9M	96.0M	45.4M
Bottom Line
Net Income	109.1M	251.0M	420.4M	416.1M	180.5M
Earnings from Cont. Ops	74.1M	208.3M	376.2M	412.3M	190.3M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	109.1M	251.0M	420.4M	416.1M	180.5M
Per Share
Basic EPS	CN¥0.48	CN¥1.08	CN¥1.80	CN¥1.75	CN¥1.04
Diluted EPS	CN¥0.48	CN¥1.08	CN¥1.80	CN¥1.75	CN¥1.04
Revenue Per Share	CN¥10.15	CN¥10.64	CN¥11.55	CN¥11.16	CN¥12.28
Shares
Basic Shares Outstanding	224.8M	232.4M	233.6M	237.8M	173.5M
Diluted Shares Outstanding	224.8M	232.4M	233.6M	237.8M	173.5M
Profitability Metrics
EBITDA	99.1M	403.3M	675.6M	683.3M	419.0M
D&A	56.8M	183.1M	180.9M	175.9M	184.4M
EBIT	42.3M	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026